Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Drug Dissolution: Compendial Testing Models II01:09

In Vitro Drug Dissolution: Compendial Testing Models II

682
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients,...
682
In Vitro Drug Dissolution: Alternative Methods01:17

In Vitro Drug Dissolution: Alternative Methods

378
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
378
In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

554
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
554
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

495
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
495
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

586
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
586
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

830
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
830

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the therapeutic potential of theobromine: a patent review.

Natural product research·2026
Same author

Chemical Profiling and Photoprotective Activity of Extracts from Colombian <i>Passiflora</i> Byproducts.

Plants (Basel, Switzerland)·2026
Same author

Effects of Plant Extracts on Human Health-2nd Edition.

Nutrients·2026
Same author

New Strategies to Improve Drug Solubility and Its Impact on Bioavailability: A Patent Review (2015-2024).

AAPS PharmSciTech·2025
Same author

Self-Emulsifying Drug Delivery System Enhances the Antidiabetic Activity of <i>Passiflora ligularis</i> Leaf Extract.

Pharmaceutics·2025
Same author

The role of mycosporine-like amino acids in skin care formulations: a patent review (2014-2024).

Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology·2025

Related Experiment Video

Updated: Apr 28, 2026

Coherent anti-Stokes Raman Scattering CARS Microscopy Visualizes Pharmaceutical Tablets During Dissolution
09:59

Coherent anti-Stokes Raman Scattering CARS Microscopy Visualizes Pharmaceutical Tablets During Dissolution

Published on: July 4, 2014

19.0K

Development of a Predictive Flow Through Cell Dissolution Method for Carbamazepine Modified-Release Tablets.

Laura Carvajal Barbosa1, Sandra Milena Echeverry1, Diana Marcela Aragón1

  • 1Departamento de Farmacia, Universidad Nacional de Colombia, Bogotá, Colombia.

CPT: Pharmacometrics & Systems Pharmacology
|April 27, 2026
PubMed
Summary

A new predictive in vitro dissolution method using USP Apparatus 4 was developed for modified-release carbamazepine. This method accurately predicts in vivo drug performance, aiding bioequivalence studies and generic drug development.

Keywords:
IVIVCcarbamazepinedissolution apparatus USP 4dissolution methodflow‐through cellmodified release

More Related Videos

Formation of Dispersible Taohong Siwu Tablets
05:44

Formation of Dispersible Taohong Siwu Tablets

Published on: February 3, 2023

2.4K
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

11.0K

Related Experiment Videos

Last Updated: Apr 28, 2026

Coherent anti-Stokes Raman Scattering CARS Microscopy Visualizes Pharmaceutical Tablets During Dissolution
09:59

Coherent anti-Stokes Raman Scattering CARS Microscopy Visualizes Pharmaceutical Tablets During Dissolution

Published on: July 4, 2014

19.0K
Formation of Dispersible Taohong Siwu Tablets
05:44

Formation of Dispersible Taohong Siwu Tablets

Published on: February 3, 2023

2.4K
Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

11.0K

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery Systems
  • Pharmacokinetics

Background:

  • Predictive in vitro dissolution methods are essential for assessing in vivo drug performance, especially for poorly soluble drugs like carbamazepine.
  • In vitro-in vivo correlations (IVIVC) are vital for linking dissolution data to pharmacokinetic profiles, streamlining bioequivalence studies and reducing clinical trial needs.

Purpose of the Study:

  • To develop a predictive in vitro dissolution method utilizing USP Apparatus 4 for a modified-release carbamazepine formulation.
  • To optimize dissolution conditions based on IVIVC principles for enhanced predictive accuracy.
  • To evaluate the method's ability to discriminate between different carbamazepine formulations and support bioequivalence assessments.

Main Methods:

  • A Box-Behnken experimental design was employed to optimize key dissolution parameters: sodium lauryl sulfate concentration, flow rate, and glass bead quantity.
  • In vitro-in vivo correlation (IVIVC) was established using the Wagner-Nelson deconvolution method, Levy plot transformation, and time-scale alignment.
  • Gohel's reconvolution equation was used for predicting absorbed fractions and plasma concentrations, with discriminatory power assessed using immediate-release (IR) and modified-release (MR) carbamazepine formulations.

Main Results:

  • The optimized IVIVC model demonstrated high predictability, achieving an R-squared value of 0.9905.
  • Prediction errors for Area Under the Curve (AUC0-t) and maximum concentration (Cmax) were low, at -6.09% and -1.94%, respectively.
  • The developed method successfully differentiated between IR and MR carbamazepine formulations, confirming its sensitivity through discriminatory analysis (f1, f2, DE, MDT).

Conclusions:

  • A predictive flow-through cell dissolution method (USP Apparatus 4) was successfully developed for modified-release carbamazepine.
  • This method serves as a robust tool for bioequivalence studies and the development of generic formulations.
  • The approach enhances formulation optimization and increases the probability of successful in vivo bioequivalence outcomes.